Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C98 - Update in Movement Disorders: Parkinson's Disease/Atypical Parkinsonism Syndromes

Monday 04/24/23
01:00 PM - 03:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Claire Henchcliffe, MD, PhD, FAAN
Movement Disorders
Participants should become familiar with current best practices in diagnosis and treatment of Parkinson's disease and atypical parkinsonian syndromes, and should receive an update on new research, clinical trials, and breakthroughs in these fields.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM EST Introduction Welcome
Claire Henchcliffe, MD, PhD, FAAN
01:05 PM - 01:30 PM EST Speaker Update in Parkinson's Disease
Pinky Agarwal, MD, FAAN
01:30 PM - 01:40 PM EST Q&A Questions and Answers
Pinky Agarwal, MD, FAAN
01:40 PM - 02:10 PM EST Speaker Update in Surgical Treatment of Parkinson's Disease and Atypical Parkinsonian Syndromes
Joohi Jimenez Shahed, MD
02:10 PM - 02:20 PM EST Q&A Questions and Answers
Joohi Jimenez Shahed, MD
02:20 PM - 02:40 PM EST Speaker Update in Atypical Parkinsonian Syndromes
Claire Henchcliffe, MD, PhD, FAAN
02:40 PM - 02:50 PM EST Q&A Questions and Answers
Claire Henchcliffe, MD, PhD, FAAN
02:50 PM - 03:00 PM EST Discussion Final Questions and Concluding Remarks
Claire Henchcliffe, MD, PhD, FAAN, Pinky Agarwal, MD, FAAN, Joohi Jimenez Shahed, MD
Faculty Disclosures
Claire Henchcliffe, MD, PhD, FAAN Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $0-$499 for serving as a Consultant for Certara. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ProJenX. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Canary Global Inc . Dr. Henchcliffe has stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics.
Pinky Agarwal, MD, FAAN Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accorda. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NQ Medical. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenx Bio . Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Accorda. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AbbVie. An immediate family member of Dr. Agarwal has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ariz Precision Medicine. Dr. Agarwal has stock in ACTINIUM PHARMACEUTICALS INC. Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. Dr. Agarwal has stock in ALTIMMUNE INC . Dr. Agarwal has stock in Aptynix Inc. Dr. Agarwal has stock in Aquestive Therapeutics. Dr. Agarwal has stock in Aurinia Pharmaceuticals. Dr. Agarwal has stock in Corcept Therapeutics. Dr. Agarwal has stock in Catalyst Pharmaceuticals. Dr. Agarwal has stock in Curis Inc. Dr. Agarwal has stock in Citius Pharmaceuticals. Dr. Agarwal has stock in Eigor Biopharma. Dr. Agarwal has stock in Fortress Biotech. Dr. Agarwal has stock in Gevo Inc. Dr. Agarwal has stock in G1 Therapeutics. Dr. Agarwal has stock in Jounce Therapeutics. Dr. Agarwal has stock in Marinus Pharnmaceuticals. Dr. Agarwal has stock in OVID Therapeutics. Dr. Agarwal has stock in Pieris Pharmaceuticals. Dr. Agarwal has stock in SIGA Technologies. Dr. Agarwal has stock in TG Therapeutics. Dr. Agarwal has stock in ARBUTUS BIOPHARMA CORP . Dr. Agarwal has stock in ATYR PHARMA INC . Dr. Agarwal has stock in ASSERTIO HOLDINGS INC . Dr. Agarwal has stock in BLUEBIRD BIO INC . Dr. Agarwal has stock in CONCERT PHARMACEUTICALS INC . Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . Dr. Agarwal has stock in GALECTO INC . Dr. Agarwal has stock in GENETIC TECHNOLOGIES LTD . Dr. Agarwal has stock in GLYCOMIMETICS INC. Dr. Agarwal has stock in IMARA INC . Dr. Agarwal has stock in INNATE PHARMA. Dr. Agarwal has stock in INTELLIA THERAPEUTICS INC . Dr. Agarwal has stock in KEMPHARM INC COM. Dr. Agarwal has stock in LAVA THERAPEUTICS . Dr. Agarwal has stock in MEREO BIOPHARMA GROUP PLC. Dr. Agarwal has stock in ORGENESIS INC. Dr. Agarwal has stock in OVID THERAPEUTICS INC . Dr. Agarwal has stock in PHASEBIO PHARMACEUTICALS INC. Dr. Agarwal has stock in PROTALIX BIOTHERAPEUTICS INC. Dr. Agarwal has stock in PUMA BIOTECHNOLOGY INC . Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. The institution of Dr. Agarwal has received research support from Acadia Pharmaceuticals. The institution of Dr. Agarwal has received research support from Adamas. The institution of Dr. Agarwal has received research support from Annexon. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Merck & Co. The institution of Dr. Agarwal has received research support from NIH/NWern Univ/PSG. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus.
Joohi Jimenez Shahed, MD Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bracket Global LLC. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for St. Jude Medical, Inc. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Omega. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. The institution of Dr. Jimenez Shahed has received research support from Michael J Fox Foundation. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with American Academy of Neurology. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on Research Grant with Florida Atlantic University. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Speaker with Tourette Association of America. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with NACCME.